Intellectual Property


We pride ourselves on running a patient-focused innovative program dedicated to advanced wound care and bleeding control. Our team is always exploring new opportunities and technologies to develop cutting-edge products and design new innovative solutions to improve patient care.

Are you interested in licensing Tricol Biomedical technology? Please contact us using the form on this page. Depending on the technology of interest, we can accommodate a range of licensing alternatives, including exclusive, non-exclusive, field of use, and other limited licenses.

HemCon® Bandage Family

(HemCon® Bandage PRO, HemCon Patch® PRO, ChitoDot®)

United States 7482503
United States 7820872
United States 8269058
United States 8313474
United States 8668924
Australia 2002312493
Canada 2450668
European Patent 1401352
European Patent 1704225
France EP1401352
France EP1704225
Germany 1401352
Germany 1704225
Israel 159339
Israel 184044
Japan 4332030
Japan 4812630
Japan 4854084
Korea 953465
Korea 953466
Korea 10-1105081
Korea 10-1148248
Netherlands 1401352
United Kingdom EP1401352
United Kingdom EP1704225

HemCon® Advanced Chitosan Uses

Biocompatible and bioabsorbable derivatized chitosan compositions
e.g., U.S. Patent Nos. 9,925,310, 9,547,011, and patents pending.

Percutaneous vascular injury treatment systems and methods
e.g., PCT/US2016/012732, published as WO/2016/112342, and patents pending.

Bioadhesive chitosan gel for controlling bleeding and for promoting healing with scar reduction without obscuring or interfering with access to a surgical field e.g., PCT/US2016/026939, published as WO/2016/164903, and patents pending.

Chitosan superfine fiber systems e.g., PCT/US17/17685, published as WO 2017/139775, and patents pending.

Interested in licensing Tricol Biomedical technology?